6533b7d2fe1ef96bd125ece3

RESEARCH PRODUCT

Visualizing the atherosclerotic plaque: a chemical perspective.

Ma Teresa AlbeldaJuan C. FriasEnrique García-españa

subject

medicine.medical_specialtyIronEarly detectionContrast MediaGadoliniumDiseaseCoronary Artery DiseaseAnginaCoronary artery diseaseCoordination ComplexesMedicineHumansMyocardial infarctionStrokeUltrasonographymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral ChemistryOrganotechnetium Compoundsmedicine.diseaseMagnetic Resonance ImagingPlaque AtheroscleroticPositron emission tomographyPositron-Emission TomographyRadiologybusinessTomography X-Ray Computed

description

Atherosclerosis is the major underlying pathologic cause of coronary artery disease. An early detection of the disease can prevent clinical sequellae such as angina, myocardial infarction, and stroke. The different imaging techniques employed to visualize the atherosclerotic plaque provide information of diagnostic and prognostic value. Furthermore, the use of contrast agents helps to improve signal-to-noise ratio providing better images. For nuclear imaging techniques and optical imaging these agents are absolutely necessary. We report on the different contrast agents that have been used, are used or may be used in future in animals, humans, or excised tissues for the distinct imaging modalities for atherosclerotic plaque imaging.

10.1039/c3cs60410ahttps://pubmed.ncbi.nlm.nih.gov/24526041